“…Therefore, Ned-19, a close analogue of NAADP, is likely to exert its inhibitory effect on TPCs in an indirect and complex manner, similar to NAADP itself. Nonetheless, the use of Ned-19 has, to a large extent, broadened our understanding of the roles of NAADP/TPCs in biological functions and diseases, especially over the past 5 years, in areas that include: cancer progression and metastasis [ 79 , 82 ], VEGF-induced angiogenesis [ 61 ], EBOV infection [ 39 ], proliferation and activation of T cells [ 83 ], autophagy of hepatocytes during liver injury [ 84 ], activation of endothelial progenitor cells [ 85 ], the noradrenaline-induced Ca 2+ response in smooth muscle cells [ 86 ], and the growth of Plasmodium , the causative agent of malaria [ 87 ].…”